Cohortias – FDA approves ‘first-in-market’ autoinjector for treating prolonged seizures.

FDA approves ‘first-in-market’ autoinjector for treating prolonged seizures. Rafa Laboratories announced today that it received FDA approval for its 10mg Midazolam autoinjector for treating status epilepticus, or prolonged seizures. Jerusalem-based…

Continue ReadingCohortias – FDA approves ‘first-in-market’ autoinjector for treating prolonged seizures.